Elevance Health Inc. Common Stock vs Heron Therapeutics Inc — how do they compare? Elevance Health Inc. Common Stock trades at $401.8 (market cap $86.95B), while Heron Therapeutics Inc trades at $0.37 (market cap $68.01M). The key difference: Elevance Health Inc. Common Stock is far larger — about 1278.5× Heron Therapeutics Inc's market cap, and Elevance Health Inc. Common Stock pays a 1.72% dividend while Heron Therapeutics Inc pays none. Which is the better fit depends on your goals.
| ELV | HRTX | |
|---|---|---|
Market Cap | $86.95B | $68.01M |
Volume | 782,706 | 1,891,941 |
Sector | Health | Health |
52-Week High | $426.79 | $1.49 |
52-Week Low | $280.74 | $0.27 |
Enterprise Value | $107.76B | $174.75M |
Dividend Yield | 1.72% | — |
Typical Hold Time | — | 35 Days |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Heron Therapeutics (HRTX) is trading at $0.39, up 17.58% today, with a bullish technical outlook from moving averages but mixed signals from oscillators. The company maintains strong gross margins of 70.07% but continues to report net losses, with Q2 2026 missing both EPS and revenue expectations. Analyst sentiment remains overwhelmingly positive with 89% buy ratings despite recent earnings disappointments and negative profitability metrics.
While analyst consensus is strongly bullish, HRTX faces significant fundamental challenges including consistent net losses, negative ROE of -78.72%, and cash flow concerns. The stock's current momentum appears driven by technical factors rather than improving fundamentals, creating a high-risk investment profile that requires careful monitoring of upcoming Q3 earnings and revenue stabilization efforts.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Elevance Health provides health plans and healthcare services. Its offerings include medical, behavioral health, pharmacy, dental, vision, and complex-care solutions, including through the Carelon business.
Read more on ELV →Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →